PROM1 and melanoma: The equivalent tumourigenicity of these melanoma subsets supports an earlier study that showed both CD133+ and CD133- populations to be equally tumourigenic [8], but contradicts findings from the same study that resulting tumours from both populations contained both CD133+ and CD133- cells with the same frequency as the parental tumour.